TABLE OF CONTENTS
Volume 25, Issue 1 (5 January 2006)
Original Articles
p53 tumor suppressor protein regulates the levels of huntingtin gene expression
Z Feng, S Jin, A Zupnick, J Hoh, E de Stanchina, S Lowe, C Prives and A J Levine
Oncogene 25: 1-7; advance online publication, November 7, 2005; doi:10.1038/sj.onc.1209021
Activation of Rac by cadherin through the c-Src–Rap1–phosphatidylinositol 3-kinase–Vav2 pathway
T Fukuyama, H Ogita, T Kawakatsu, M Inagaki and Y Takai
Oncogene 25: 8-19; advance online publication, September 19, 2005; doi:10.1038/sj.onc.1209010
MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90
J Ren, A Bharti, D Raina, W Chen, R Ahmad and D Kufe
Oncogene 25: 20-31; advance online publication, September 12, 2005; doi:10.1038/sj.onc.1209012
Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling
T DeAngelis, J Chen, A Wu, M Prisco and R Baserga
Oncogene 25: 32-42; advance online publication, September 19, 2005; doi:10.1038/sj.onc.1209013
Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase
Q Wang, Y Zhou, X Wang and B M Evers
Oncogene 25: 43-50; advance online publication, November 7, 2005; doi:10.1038/sj.onc.1209004
Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a
D Ndisang, D J Faulkes, D Gascoyne, S A Lee, B J Ripley, M Sindos, A Singer, V Budhram-Mahadeo, J Cason and D S Latchman
Oncogene 25: 51-60; advance online publication, October 10, 2005; doi:10.1038/sj.onc.1209006
Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms
C J Anderson, S F Hoare, M Ashcroft, A E Bilsland and W N Keith
Oncogene 25: 61-69; advance online publication, September 19, 2005; doi:10.1038/sj.onc.1209011
The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs
Y Xie, K Xu, B Dai, Z Guo, T Jiang, H Chen and Y Qiu
Oncogene 25: 70-78; advance online publication, September 26, 2005; doi:10.1038/sj.onc.1209058
Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15
C Bartholomeusz, H Itamochi, M Nitta, H Saya, M H Ginsberg and N T Ueno
Oncogene 25: 79-90; advance online publication, September 19, 2005; doi:10.1038/sj.onc.1209014
Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer
I M Seiden-Long, K R Brown, W Shih, D A Wigle, N Radulovich, I Jurisica and M-S Tsao
Oncogene 25: 91-102; advance online publication, September 12, 2005; doi:10.1038/sj.onc.1209005
Expression of Hugl-1 is strongly reduced in malignant melanoma
S Kuphal, S Wallner, C C Schimanski, F Bataille, P Hofer, S Strand, D Strand and A K Bosserhoff
Oncogene 25: 103-110; advance online publication, September 19, 2005; doi:10.1038/sj.onc.1209008
Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development
L Hummerich, R Müller, J Hess, F Kokocinski, M Hahn, G Fürstenberger, C Mauch, P Lichter and P Angel
Oncogene 25: 111-121; advance online publication, October 17, 2005; doi:10.1038/sj.onc.1209016
Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly
P F T Cezar-de-Mello, V Nascimento-Silva, C G Villela and I M Fierro
Oncogene 25: 122-129; advance online publication, August 29, 2005; doi:10.1038/sj.onc.1209002
Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification
Y H Kim, L Girard, C P Giacomini, P Wang, T Hernandez-Boussard, R Tibshirani, J D Minna and J R Pollack
Oncogene 25: 130-138; advance online publication, August 22, 2005; doi:10.1038/sj.onc.1208997
Short Communications
Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability
K Koinuma, Y Yamashita, W Liu, H Hatanaka, K Kurashina, T Wada, S Takada, R Kaneda, Y L Choi, S-I Fujiwara, Y Miyakura, H Nagai and H Mano
Oncogene 25: 139-146; advance online publication, October 10, 2005; doi:10.1038/sj.onc.1209009
FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance
J R Taylor, N Brownlow, J Domin and N J Dibb
Oncogene 25: 147-151; advance online publication, September 19, 2005; doi:10.1038/sj.onc.1209007
Unique and overlapping substrate specificities of caspase-8 and caspase-10
U Fischer, C Stroh and K Schulze-Osthoff
Oncogene 25: 152-159; advance online publication, September 26, 2005; doi:10.1038/sj.onc.1209015
